Annual EBITDA
-$68.28 M
+$17.87 M+20.74%
December 31, 2023
Summary
- As of February 7, 2025, HCAT annual EBITDA is -$68.28 million, with the most recent change of +$17.87 million (+20.74%) on December 31, 2023.
- During the last 3 years, HCAT annual EBITDA has risen by +$17.63 million (+20.52%).
- HCAT annual EBITDA is now -72.22% below its all-time high of -$39.65 million, reached on December 31, 2017.
Performance
HCAT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$908.00 K
+$1.86 M+195.08%
September 30, 2024
Summary
- As of February 7, 2025, HCAT quarterly EBITDA is $908.00 thousand, with the most recent change of +$1.86 million (+195.08%) on September 30, 2024.
- Over the past year, HCAT quarterly EBITDA has increased by +$9.03 million (+111.18%).
- HCAT quarterly EBITDA is now at all-time high.
Performance
HCAT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$26.21 M
+$10.87 M+29.31%
September 30, 2024
Summary
- As of February 7, 2025, HCAT TTM EBITDA is -$26.21 million, with the most recent change of +$10.87 million (+29.31%) on September 30, 2024.
- Over the past year, HCAT TTM EBITDA has increased by +$29.89 million (+53.28%).
- HCAT TTM EBITDA is now -158.67% below its all-time high of -$10.13 million, reached on March 31, 2018.
Performance
HCAT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HCAT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | +111.2% | +53.3% |
| 3 y3 years | +20.5% | +102.9% | +75.0% |
| 5 y5 years | -29.6% | +105.2% | +44.6% |
HCAT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.7% | at high | +102.6% | at high | +75.3% |
| 5 y | 5-year | -44.3% | +35.7% | at high | +102.6% | at high | +75.3% |
| alltime | all time | -72.2% | +35.7% | at high | +102.6% | -158.7% | +75.3% |
Health Catalyst EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $908.00 K(-195.1%) | -$26.21 M(-29.3%) |
| Jun 2024 | - | -$955.00 K(-88.2%) | -$37.07 M(-33.9%) |
| Mar 2024 | - | -$8.12 M(-55.0%) | -$56.09 M(-17.9%) |
| Dec 2023 | -$68.28 M(-20.7%) | -$18.04 M(+81.1%) | -$68.28 M(-5.8%) |
| Sep 2023 | - | -$9.96 M(-50.1%) | -$72.49 M(-22.8%) |
| Jun 2023 | - | -$19.97 M(-1.7%) | -$93.92 M(+0.0%) |
| Mar 2023 | - | -$20.31 M(-8.7%) | -$93.90 M(+9.0%) |
| Dec 2022 | -$86.15 M(-18.8%) | -$22.25 M(-29.1%) | -$86.15 M(-12.5%) |
| Sep 2022 | - | -$31.40 M(+57.4%) | -$98.42 M(-0.2%) |
| Jun 2022 | - | -$19.95 M(+58.9%) | -$98.58 M(-3.7%) |
| Mar 2022 | - | -$12.55 M(-63.6%) | -$102.35 M(-3.6%) |
| Dec 2021 | -$106.12 M | -$34.52 M(+9.4%) | -$106.12 M(+1.3%) |
| Sep 2021 | - | -$31.56 M(+33.0%) | -$104.77 M(+14.7%) |
| Jun 2021 | - | -$23.72 M(+45.3%) | -$91.34 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.32 M(-50.8%) | -$87.99 M(+2.4%) |
| Dec 2020 | -$85.91 M(+81.5%) | -$33.17 M(+83.0%) | -$85.91 M(+30.7%) |
| Sep 2020 | - | -$18.12 M(-11.1%) | -$65.75 M(+1.1%) |
| Jun 2020 | - | -$20.38 M(+43.0%) | -$65.06 M(+26.5%) |
| Mar 2020 | - | -$14.24 M(+9.5%) | -$51.42 M(+8.7%) |
| Dec 2019 | -$47.32 M(-10.2%) | -$13.01 M(-25.4%) | -$47.32 M(+4.1%) |
| Sep 2019 | - | -$17.43 M(+159.0%) | -$45.47 M(+7.7%) |
| Jun 2019 | - | -$6.73 M(-33.7%) | -$42.22 M(-19.8%) |
| Mar 2019 | - | -$10.15 M(-9.0%) | -$52.66 M(+0.0%) |
| Dec 2018 | -$52.68 M(+32.9%) | -$11.16 M(-21.3%) | -$52.64 M(+26.9%) |
| Sep 2018 | - | -$14.18 M(-17.4%) | -$41.48 M(+51.9%) |
| Jun 2018 | - | -$17.17 M(+69.5%) | -$27.30 M(+169.5%) |
| Mar 2018 | - | -$10.13 M | -$10.13 M |
| Dec 2017 | -$39.65 M | - | - |
FAQ
- What is Health Catalyst annual EBITDA?
- What is the all time high annual EBITDA for Health Catalyst?
- What is Health Catalyst annual EBITDA year-on-year change?
- What is Health Catalyst quarterly EBITDA?
- What is the all time high quarterly EBITDA for Health Catalyst?
- What is Health Catalyst quarterly EBITDA year-on-year change?
- What is Health Catalyst TTM EBITDA?
- What is the all time high TTM EBITDA for Health Catalyst?
- What is Health Catalyst TTM EBITDA year-on-year change?
What is Health Catalyst annual EBITDA?
The current annual EBITDA of HCAT is -$68.28 M
What is the all time high annual EBITDA for Health Catalyst?
Health Catalyst all-time high annual EBITDA is -$39.65 M
What is Health Catalyst annual EBITDA year-on-year change?
Over the past year, HCAT annual EBITDA has changed by +$17.87 M (+20.74%)
What is Health Catalyst quarterly EBITDA?
The current quarterly EBITDA of HCAT is $908.00 K
What is the all time high quarterly EBITDA for Health Catalyst?
Health Catalyst all-time high quarterly EBITDA is $908.00 K
What is Health Catalyst quarterly EBITDA year-on-year change?
Over the past year, HCAT quarterly EBITDA has changed by +$9.03 M (+111.18%)
What is Health Catalyst TTM EBITDA?
The current TTM EBITDA of HCAT is -$26.21 M
What is the all time high TTM EBITDA for Health Catalyst?
Health Catalyst all-time high TTM EBITDA is -$10.13 M
What is Health Catalyst TTM EBITDA year-on-year change?
Over the past year, HCAT TTM EBITDA has changed by +$29.89 M (+53.28%)